SINGAPORE (Reuters) - A company in Singapore has developed a breathalyser test for the new coronavirus which it says will enable people to know whether they are infected in under a minute.
Breathonix, a startup firm from the National University of Singapore, says its test achieved more than 90% accuracy in a pilot clinical trial of 180 people in the city-state and hopes to get regulatory approval early next year.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!